BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 02-28. Amounts in USD.

Revenue TTM

0 Q4 '16: 0 Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '26: 0 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '15: -3.4M Q3 '15: -3.1M Q4 '15: -2.9M Q1 '16: -2.6M Q2 '16: -2.3M Q3 '16: -2.1M Q4 '16: -1.9M Q1 '17: -1.8M Q2 '17: -1.6M Q3 '17: -1.6M Q4 '17: -1.5M Q1 '18: -1.6M Q2 '18: -1.6M Q3 '18: -1.6M Q4 '18: -1.6M Q1 '19: -1.6M Q2 '19: -1.6M Q3 '19: -1.6M Q4 '19: -1.6M Q1 '20: -1.7M Q2 '20: -1.7M Q3 '20: -1.7M Q4 '20: -1.6M Q1 '21: -1.6M Q2 '21: -1.5M Q3 '21: -1.3M Q4 '21: -1.3M Q1 '22: -1.2M Q2 '22: -1.1M Q3 '22: -1.1M Q4 '22: -976.7K Q1 '23: -892.1K Q2 '23: -883.3K Q3 '23: -871.2K Q4 '23: -916.3K Q1 '24: -972K Q2 '24: -1M Q3 '24: -1.2M Q4 '24: -1.3M Q1 '25: -1.4M Q2 '25: -1.5M Q3 '25: -1.5M Q4 '25: -1.4M Q1 '26: -1.3M Q2 '26: -1.3M Q3 '26: -1.3M Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q1 '22 Q3 '23 Q1 '25 Q3 '26

Net Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q4 '11: -5M Q1 '12: -5.2M Q2 '12: -5.7M Q3 '12: -6.4M Q4 '12: -7.2M Q1 '13: -7.3M Q2 '13: -7.3M Q3 '13: -7M Q4 '13: -6.5M Q1 '14: -6.2M Q2 '14: -5.5M Q3 '14: -4.9M Q4 '14: -4.3M Q1 '15: -3.8M Q2 '15: -3.4M Q3 '15: -3.1M Q4 '15: -2.9M Q1 '16: -2.6M Q2 '16: -2.3M Q3 '16: -2.1M Q4 '16: -1.9M Q1 '17: -1.8M Q2 '17: -1.6M Q3 '17: -1.6M Q4 '17: -1.5M Q1 '18: -1.6M Q2 '18: -1.6M Q3 '18: -1.6M Q4 '18: -1.6M Q1 '19: -1.6M Q2 '19: -1.6M Q3 '19: -1.6M Q4 '19: -1.6M Q1 '20: -1.7M Q2 '20: -1.7M Q3 '20: -1.7M Q4 '20: -1.6M Q1 '21: -1.6M Q2 '21: -1.5M Q3 '21: -1.3M Q4 '21: -1.2M Q1 '22: -1.1M Q2 '22: -958.5K Q3 '22: -958.9K Q4 '22: -976.7K Q1 '23: -892.1K Q2 '23: -883.3K Q3 '23: -871.2K Q4 '23: -916.3K Q1 '24: -972K Q2 '24: -1M Q3 '24: -1.2M Q4 '24: -1.3M Q1 '25: -1.4M Q2 '25: -1.5M Q3 '25: -1.5M Q4 '25: -1.4M Q1 '26: -1.3M Q2 '26: -1.3M Q3 '26: -1.3M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-1.5M -1M -500K 0 500K 1M 1.5M Q2 '12: -549.4K Q3 '12: -494.4K Q4 '12: -504.1K Q1 '13: -535.1K Q2 '13: -660K Q3 '13: -653.9K Q4 '13: -671.3K Q1 '14: -695K Q2 '14: -496.7K Q3 '14: -473.2K Q4 '14: -438.4K Q1 '15: -404.8K Q2 '15: -389.7K Q3 '15: -415.4K Q4 '15: -353.7K Q1 '16: -303.2K Q2 '16: -260.6K Q3 '16: -193.8K Q4 '16: -251K Q1 '17: -250.5K Q2 '17: -278.7K Q3 '17: -324.5K Q4 '17: -314.5K Q1 '18: -291K Q2 '18: -319.3K Q3 '18: -297.2K Q4 '18: -319.5K Q1 '19: -381.2K Q2 '19: -418.1K Q3 '19: -477.6K Q4 '19: -477.5K Q1 '20: -497K Q2 '20: -516.8K Q3 '20: -535.9K Q4 '20: -530.1K Q1 '21: -477.8K Q2 '21: -469K Q3 '21: -444.8K Q4 '21: -394.4K Q1 '22: -395.3K Q2 '22: -345.4K Q3 '22: -316.7K Q4 '22: -325.1K Q1 '23: -279.8K Q2 '23: -281.9K Q3 '23: -234.3K Q4 '23: -249.5K Q1 '24: -275.7K Q2 '24: -305.9K Q3 '24: -459.4K Q4 '24: -523.8K Q1 '25: -518K Q2 '25: -546.3K Q3 '25: -1.2M Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q1 '22 Q4 '23 Q3 '25

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '11: 131.4M Q3 '11: 131.4M Q1 '12: 131.4M Q2 '12: 131.4M Q3 '12: 131.4M Q1 '13: 131.4M Q3 '21: 131.4M Q1 '22: 131.4M Q2 '22: 131.4M Q3 '22: 131.4M Q1 '23: 131.4M Q2 '23: 131.4M Q3 '23: 131.4M Q1 '24: 131.4M Q2 '24: 131.4M Q3 '24: 131.4M Q1 '25: 131.4M Q2 '25: 131.4M Q3 '25: 131.4M Q1 '26: 131.4M Q2 '26: 131.4M Q3 '26: 131.4M Q2 '11 Q2 '12 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.04 -0.03 -0.01 0.00 0.01 0.03 0.04 Q4 '11: -0.04 Q1 '12: -0.04 Q2 '12: -0.04 Q3 '12: -0.04 Q4 '12: -0.04 Q1 '13: -0.04 Q2 '13: -0.04 Q3 '13: -0.04 Q4 '13: -0.04 Q1 '14: -0.04 Q2 '14: -0.04 Q3 '14: -0.04 Q4 '14: -0.03 Q1 '15: -0.03 Q2 '15: -0.03 Q3 '15: -0.03 Q4 '15: -0.03 Q1 '16: -0.02 Q2 '16: -0.01 Q3 '16: 0.00 Q4 '16: -0.01 Q1 '17: -0.01 Q2 '17: -0.01 Q3 '17: -0.01 Q4 '17: 0.00 Q1 '18: 0.00 Q2 '18: 0.00 Q3 '18: 0.00 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.